Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)

This study is ongoing, but not recruiting participants.

Study NCT00256750 Information provided by Bristol-Myers Squibb

First Received: November 15, 2005 Last Updated: February 2, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2014
Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)
Extension Request:	Submission Date: April 29, 2010 Status: Submitted